Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chemotherapy, Second-Look Surgery, and Conformal Radiation in Young Children with Medulloblastoma
NCT00006461Phase 3Completed
- Sponsor
- Children's Oncology Group
- Start
- Oct 2000
- Primary completion
- Sep 2007
- Modality
- Monoclonal Antibodies, Lipid-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Cisplatin micelle injection (HA132), cyclophosphamide, vincristine sulfate liposome injection, etoposide in medulloblastoma, primitive neuroectodermal tumor (PNET), sponsored by Children's Oncology Group. Started Oct 2000; status: completed.
02
Drugs
Cisplatin micelle injection (HA132)cyclophosphamidevincristine sulfate liposome injectionetoposide
03
Conditions
medulloblastomaprimitive neuroectodermal tumor (PNET)
Beyond the preview
Go deeper on NCT00006461.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006461.